Sergio Traversa, Relmada Therapeutics’ chief executive officer, bought 200,000 shares across two transactions priced from $4.10 to $4.18 per share. The purchases left him with 1,500,000 shares, giving investors a clear reference for the CEO’s reported post-transaction ownership in the company.

Key Highlights

  • The purchases took place on September 9 and September 10, 2026.
  • All transactions carried transaction code P.
  • Sergio Traversa’s reported ownership was 1,500,000 shares after the transactions.

Relmada Therapeutics, Inc. (NASDAQ: RLMD) Chief Executive Officer Sergio Traversa bought 200,000 shares across two transactions priced from $4.10 to $4.18 per share. The purchases left Traversa with 1,500,000 shares.

The transactions occurred on September 9 and September 10, 2026. The transactions carried code P. The disclosed prices ranged from $4.10 to $4.18 per share. Traversa made the purchases in his role as Relmada Therapeutics’ chief executive officer.

CEO Holding Reaches 1,500,000 Shares

Following the transactions, Traversa owned 1,500,000 shares. The reported ownership figure is the holding stated after both purchases were completed.